Thursday, July 7, 2016

INTERVIEW-Blockbuster hopes grow for Ablynx drug backed by AbbVie

July 7 (Reuters) - Ablynx's hopes for a potential

multibillion-dollar drug were boosted on Thursday by strong

clinical trial results in rheumatoid arthritis, vindicating a

$175 million bet placed on...

Read more

No comments:

Post a Comment